Previous Page  2 / 5 Next Page
Information
Show Menu
Previous Page 2 / 5 Next Page
Page Background

Page 6

Notes:

allied

academies

Journal of Brain and Neurology| Volume: 2

November 05-06, 2018 | Edinburgh, Scotland

Brain Disorders and Therapeutics

Mental Heal th and Psychology

5

th

International Conference on

Joint Event

&

C

entral nervous system inflammatory demyelinating disease

(CIDD) encompasses a broad spectrum of disorders such as

multiple sclerosis (MS), acute disseminated encephalomyelitis

(ADEM) and neuromyelitis optica (NMO). Two cases of CIDD

with unusual clinical features are presented. In both cases,

histopathological examination played pivotal roles in the

anatomical diagnosis. Case 1 is a 51 year old female who

presented with headache, progressive aphasia and hemiparesis

without preceding infection or vaccination. Based on MRI

and negative oligoclonal bands in the CSF, a clinical diagnosis

of ADEM was made. However, brain biopsy of the affected

cerebral white matter revealed both pathological features

of ADEM and early stage of active MS including perivenular

demyelination, confluent plaque-like demyelination, and

subpial demyelination. Case 2 is an autopsied 73 year old

female who had been diagnosed as NMO at age 63 based on

typical clinical/radiological features and positive serum AQP4

antibody. One year before death, she was treated for an acute

myocardial infarction, and onemonth before death she suffered

a massive basal ganglia stroke diagnosed with CT. On autopsy,

the corresponding basal ganglia revealed large necrotic lesions

associatedwithseveralpathologicalsignaturesofNMOincluding

inflammatory cell infiltration, perivascular complement

deposition, and the presence of numerous corpora amylacea

phagocytosedby infiltratingmacrophages. These cases illustrate

the importance of neuropathological examination which

might be of interest in considering the pathogenesis of CIDDs.

Speaker Biography

Shinji Ohara is the Vice Director, Matsumoto Medical Center, Matsumoto Japan. He

graduatedfromTohokuUniversitySchoolofMedicine,Sendai,Japan,andfrompostdoctoral

course (Neuropathology) at Brain Research Institute, Niigata University, Niigata, Japan in

1986. He then completed Neurology Residency Program at Department of Neurology,

Washington University School of Medicine, St. Louis, MO, USA. Since 1995, he has served

as Director of Department of Neurology at Matsumoto Medical Center, Matsumoto, Japan

e:

oharas@hosp.go.jp

Shinji Ohara

Matsumoto Medical Center, Japan

Central nervous system inflammatory demyelinating diseases with unusual clinical

features - Lessons learned from neuropathology